Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40M9J | ISIN: US83558L3033 | Ticker-Symbol: O8Z
Lang & Schwarz
21.11.24
07:00 Uhr
2,520 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SONOMA PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
SONOMA PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,4802,56007:00
0,0000,00016.10.

Aktuelle News zur SONOMA PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.11.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn-based Wound Care Hydrogel285BOULDER, CO / ACCESSWIRE / November 11, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...
► Artikel lesen
11.11.Sonoma Pharmaceuticals erhält FDA-Zulassung für Hydrogel4
11.11.Sonoma Pharmaceuticals gains FDA clearance for hydrogel2
08.11.Sonoma Pharmaceuticals GAAP EPS of -$0.59, revenue of $3.6M7
07.11.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results179Revenue increased 31% for the quarter compared to same period prior yearPositive cash flows from operations of $0.35 million for the quarterNet loss improved 59% for the quarter compared to same period...
► Artikel lesen
07.11.Sonoma Pharmaceuticals, Inc. - 10-Q, Quarterly Report3
SONOMA PHARMACEUTICALS Aktie jetzt für 0€ handeln
31.10.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf202BOULDER, CO / ACCESSWIRE / October 31, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous...
► Artikel lesen
22.10.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada218BOULDER, CO / ACCESSWIRE / October 22, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...
► Artikel lesen
22.10.Sonoma Pharmaceuticals, Inc. - 8-K, Current Report2
21.10.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences224BOULDER, CO / ACCESSWIRE / October 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...
► Artikel lesen
20.09.Sonoma Pharmaceuticals, Inc. - 8-K, Current Report1
19.09.Sonoma Pharmaceuticals regains Nasdaq compliance3
19.09.Sonoma Pharmaceuticals erfüllt wieder Nasdaq-Anforderungen9
19.09.Sonoma Pharmaceuticals regains compliance with Nasdaq minimum bid price rule3
19.09.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule214BOULDER, CO / ACCESSWIRE / September 19, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...
► Artikel lesen
17.09.Sonoma Pharmaceuticals gets FDA nod for OTC eye care product6
17.09.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn-Based Solution228BOULDER, CO / ACCESSWIRE / September 17, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...
► Artikel lesen
11.09.Sonoma Pharmaceuticals erweitert Augenpflegelinie in Zusammenarbeit mit EMC Pharma8
11.09.Sonoma Pharmaceuticals expands eye care line with EMC Pharma2
11.09.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line329BOULDER, CO / ACCESSWIRE / September 11, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...
► Artikel lesen
Seite:  Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1